Physician profile
Peter Shedden
NPI 1861464893
$45,754.31
in general payments reported to CMS, 2019-2025
14 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $18K · 2021: $24K · 2022: $381 · 2023: $333 · 2024: $2,088 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483 · Travel and Lodging: $1,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.49 |
| Travel and Lodging | $1,334.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $41,979.87 | 2019-2024 | |
| Orthofix Medical, INC. | $1,523.84 | 2023-2025 | 7d Surgical System, Mariner, Meridian |
| Medtronic, INC. | $877.67 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Medtronic USA, INC. | $555.25 | 2019 | |
| Abbott Laboratories | $185.95 | 2022 | |
| Zap Surgical Systems, INC. | $160.04 | 2021 | |
| Intrinsic Therapeutics | $159.36 | 2024 | Barricaid Acd (Annular Closure Device) |
| Genesys Orthopedics Systems, L.L.C. | $143.00 | 2023 | Binary |
| Elekta, INC. | $53.89 | 2020 | |
| Arbor Pharmaceuticals, INC. | $36.79 | 2020 | |
| Depuy Synthes Sales INC. | $31.50 | 2023 | Matrixneuro |
| Surgalign Spine Technologies, INC. | $18.38 | 2020 | |
| Integra Lifesciences Corporation | $15.49 | 2022 | |
| Csl Behring | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shedden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.